Description
VIGLIPTIN M 500MG Tablets – Pack of 30
Combination Therapy for Effective Type 2 Diabetes Management
VIGLIPTIN M 500MG Tablets combine Metformin Hydrochloride 500mg with Sitagliptin, providing a synergistic effect to improve blood glucose control in patients with Type 2 diabetes mellitus. Metformin decreases hepatic glucose production and increases insulin sensitivity, while Sitagliptin enhances insulin secretion and decreases glucagon levels, aiding in better glycemic regulation.
Key Features:
-
Dual-action medication targeting multiple pathways in diabetes control
-
Helps lower both fasting and post-meal blood sugar levels
-
Convenient oral dosing to enhance patient compliance
-
Suitable for patients with inadequate glycemic control on monotherapy
-
Generally well-tolerated with a low risk of hypoglycemia
Usage Instructions:
Take one tablet daily or as prescribed by your healthcare provider, preferably with meals to minimize gastrointestinal discomfort. Regular blood sugar monitoring is advised during treatment.
Precautions:
-
Not suitable for Type 1 diabetes or diabetic ketoacidosis
-
Inform your doctor about any kidney, liver, or heart conditions before use
-
Seek immediate medical attention if symptoms of lactic acidosis occur
-
Store in a cool, dry place away from direct sunlight
-
Keep out of reach of children
Reviews
There are no reviews yet.